In vivo study with CGM097 (an MDM2 inhibitor) and OTX015 (a Bromodomain and Extra-terminal domain (BET) inhibitor) showed the reactivation of p53 in neuroblastoma. The gene discussed is MDM2; the disease is neuroblastoma.